1. Home
  2. Pharma & Healthcare
  3. Global Gastrointestinal Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Gastrointestinal Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Publication Month: Apr 2023 | No. of Pages: 104 Published By: Global Info Research
Single User License: US $ 3480
Corporate User License: US $ 6960

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
According to our (Global Info Research) latest study, the global Gastrointestinal market size was valued at USD 35710 million in 2022 and is forecast to a readjusted size of USD 44400 million by 2029 with a CAGR of 3.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.
Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.
In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.
This report is a detailed and comprehensive analysis for global Gastrointestinal market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Gastrointestinal market size and forecasts, in consumption value ($ Million), 2018-2029
Global Gastrointestinal market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Gastrointestinal market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Gastrointestinal market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gastrointestinal
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gastrointestinal market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZenec, Sanofi, Bayer, Pfizer and GlaxoSmithKline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Gastrointestinal market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Market segment by Application
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Others
Market segment by players, this report covers
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gastrointestinal product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastrointestinal, with revenue, gross margin and global market share of Gastrointestinal from 2018 to 2023.
Chapter 3, the Gastrointestinal competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gastrointestinal market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal.
Chapter 13, to describe Gastrointestinal research findings and conclusion.

1 Market Overview
1.1 Product Overview and Scope of Gastrointestinal
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gastrointestinal by Type
1.3.1 Overview: Global Gastrointestinal Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Gastrointestinal Consumption Value Market Share by Type in 2022
1.3.3 Prescription Gastrointestinal Drug
1.3.4 OTC Gastrointestinal Drug
1.4 Global Gastrointestinal Market by Application
1.4.1 Overview: Global Gastrointestinal Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Chronic Gastritis
1.4.3 Functional Dyspepsia
1.4.4 Peptic Ulcer
1.4.5 Acute Gastroenteritis
1.4.6 Others
1.5 Global Gastrointestinal Market Size & Forecast
1.6 Global Gastrointestinal Market Size and Forecast by Region
1.6.1 Global Gastrointestinal Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Gastrointestinal Market Size by Region, (2018-2029)
1.6.3 North America Gastrointestinal Market Size and Prospect (2018-2029)
1.6.4 Europe Gastrointestinal Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Gastrointestinal Market Size and Prospect (2018-2029)
1.6.6 South America Gastrointestinal Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Gastrointestinal Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 AstraZenec
2.1.1 AstraZenec Details
2.1.2 AstraZenec Major Business
2.1.3 AstraZenec Gastrointestinal Product and Solutions
2.1.4 AstraZenec Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AstraZenec Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Gastrointestinal Product and Solutions
2.2.4 Sanofi Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Gastrointestinal Product and Solutions
2.3.4 Bayer Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bayer Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Gastrointestinal Product and Solutions
2.4.4 Pfizer Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Gastrointestinal Product and Solutions
2.5.4 GlaxoSmithKline Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Gastrointestinal Product and Solutions
2.6.4 Teva Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Recent Developments and Future Plans
2.7 Zeria（Tillotts）
2.7.1 Zeria（Tillotts） Details
2.7.2 Zeria（Tillotts） Major Business
2.7.3 Zeria（Tillotts） Gastrointestinal Product and Solutions
2.7.4 Zeria（Tillotts） Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Zeria（Tillotts） Recent Developments and Future Plans
2.8 Perrigo
2.8.1 Perrigo Details
2.8.2 Perrigo Major Business
2.8.3 Perrigo Gastrointestinal Product and Solutions
2.8.4 Perrigo Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Perrigo Recent Developments and Future Plans
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Gastrointestinal Product and Solutions
2.9.4 Boehringer Ingelheim Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Boehringer Ingelheim Recent Developments and Future Plans
2.10 Purdue Pharma
2.10.1 Purdue Pharma Details
2.10.2 Purdue Pharma Major Business
2.10.3 Purdue Pharma Gastrointestinal Product and Solutions
2.10.4 Purdue Pharma Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Purdue Pharma Recent Developments and Future Plans
2.11 C.B. Fleet
2.11.1 C.B. Fleet Details
2.11.2 C.B. Fleet Major Business
2.11.3 C.B. Fleet Gastrointestinal Product and Solutions
2.11.4 C.B. Fleet Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 C.B. Fleet Recent Developments and Future Plans
2.12 Abbott
2.12.1 Abbott Details
2.12.2 Abbott Major Business
2.12.3 Abbott Gastrointestinal Product and Solutions
2.12.4 Abbott Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Abbott Recent Developments and Future Plans
2.13 Jiangzhong
2.13.1 Jiangzhong Details
2.13.2 Jiangzhong Major Business
2.13.3 Jiangzhong Gastrointestinal Product and Solutions
2.13.4 Jiangzhong Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Jiangzhong Recent Developments and Future Plans
2.14 Xian-Janssen
2.14.1 Xian-Janssen Details
2.14.2 Xian-Janssen Major Business
2.14.3 Xian-Janssen Gastrointestinal Product and Solutions
2.14.4 Xian-Janssen Gastrointestinal Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Xian-Janssen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gastrointestinal Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Gastrointestinal by Company Revenue
3.2.2 Top 3 Gastrointestinal Players Market Share in 2022
3.2.3 Top 6 Gastrointestinal Players Market Share in 2022
3.3 Gastrointestinal Market: Overall Company Footprint Analysis
3.3.1 Gastrointestinal Market: Region Footprint
3.3.2 Gastrointestinal Market: Company Product Type Footprint
3.3.3 Gastrointestinal Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Gastrointestinal Consumption Value and Market Share by Type (2018-2023)
4.2 Global Gastrointestinal Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Gastrointestinal Consumption Value Market Share by Application (2018-2023)
5.2 Global Gastrointestinal Market Forecast by Application (2024-2029)
6 North America
6.1 North America Gastrointestinal Consumption Value by Type (2018-2029)
6.2 North America Gastrointestinal Consumption Value by Application (2018-2029)
6.3 North America Gastrointestinal Market Size by Country
6.3.1 North America Gastrointestinal Consumption Value by Country (2018-2029)
6.3.2 United States Gastrointestinal Market Size and Forecast (2018-2029)
6.3.3 Canada Gastrointestinal Market Size and Forecast (2018-2029)
6.3.4 Mexico Gastrointestinal Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Gastrointestinal Consumption Value by Type (2018-2029)
7.2 Europe Gastrointestinal Consumption Value by Application (2018-2029)
7.3 Europe Gastrointestinal Market Size by Country
7.3.1 Europe Gastrointestinal Consumption Value by Country (2018-2029)
7.3.2 Germany Gastrointestinal Market Size and Forecast (2018-2029)
7.3.3 France Gastrointestinal Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Gastrointestinal Market Size and Forecast (2018-2029)
7.3.5 Russia Gastrointestinal Market Size and Forecast (2018-2029)
7.3.6 Italy Gastrointestinal Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Gastrointestinal Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Gastrointestinal Market Size by Region
8.3.1 Asia-Pacific Gastrointestinal Consumption Value by Region (2018-2029)
8.3.2 China Gastrointestinal Market Size and Forecast (2018-2029)
8.3.3 Japan Gastrointestinal Market Size and Forecast (2018-2029)
8.3.4 South Korea Gastrointestinal Market Size and Forecast (2018-2029)
8.3.5 India Gastrointestinal Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Gastrointestinal Market Size and Forecast (2018-2029)
8.3.7 Australia Gastrointestinal Market Size and Forecast (2018-2029)
9 South America
9.1 South America Gastrointestinal Consumption Value by Type (2018-2029)
9.2 South America Gastrointestinal Consumption Value by Application (2018-2029)
9.3 South America Gastrointestinal Market Size by Country
9.3.1 South America Gastrointestinal Consumption Value by Country (2018-2029)
9.3.2 Brazil Gastrointestinal Market Size and Forecast (2018-2029)
9.3.3 Argentina Gastrointestinal Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Gastrointestinal Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Gastrointestinal Market Size by Country
10.3.1 Middle East & Africa Gastrointestinal Consumption Value by Country (2018-2029)
10.3.2 Turkey Gastrointestinal Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Gastrointestinal Market Size and Forecast (2018-2029)
10.3.4 UAE Gastrointestinal Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Gastrointestinal Market Drivers
11.2 Gastrointestinal Market Restraints
11.3 Gastrointestinal Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Gastrointestinal Industry Chain
12.2 Gastrointestinal Upstream Analysis
12.3 Gastrointestinal Midstream Analysis
12.4 Gastrointestinal Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Tables and Figures

List of Tables
Table 1. Global Gastrointestinal Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Gastrointestinal Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Gastrointestinal Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Gastrointestinal Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AstraZenec Company Information, Head Office, and Major Competitors
Table 6. AstraZenec Major Business
Table 7. AstraZenec Gastrointestinal Product and Solutions
Table 8. AstraZenec Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AstraZenec Recent Developments and Future Plans
Table 10. Sanofi Company Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Gastrointestinal Product and Solutions
Table 13. Sanofi Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Sanofi Recent Developments and Future Plans
Table 15. Bayer Company Information, Head Office, and Major Competitors
Table 16. Bayer Major Business
Table 17. Bayer Gastrointestinal Product and Solutions
Table 18. Bayer Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Bayer Recent Developments and Future Plans
Table 20. Pfizer Company Information, Head Office, and Major Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer Gastrointestinal Product and Solutions
Table 23. Pfizer Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Pfizer Recent Developments and Future Plans
Table 25. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 26. GlaxoSmithKline Major Business
Table 27. GlaxoSmithKline Gastrointestinal Product and Solutions
Table 28. GlaxoSmithKline Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. GlaxoSmithKline Recent Developments and Future Plans
Table 30. Teva Company Information, Head Office, and Major Competitors
Table 31. Teva Major Business
Table 32. Teva Gastrointestinal Product and Solutions
Table 33. Teva Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Teva Recent Developments and Future Plans
Table 35. Zeria（Tillotts） Company Information, Head Office, and Major Competitors
Table 36. Zeria（Tillotts） Major Business
Table 37. Zeria（Tillotts） Gastrointestinal Product and Solutions
Table 38. Zeria（Tillotts） Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Zeria（Tillotts） Recent Developments and Future Plans
Table 40. Perrigo Company Information, Head Office, and Major Competitors
Table 41. Perrigo Major Business
Table 42. Perrigo Gastrointestinal Product and Solutions
Table 43. Perrigo Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Perrigo Recent Developments and Future Plans
Table 45. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 46. Boehringer Ingelheim Major Business
Table 47. Boehringer Ingelheim Gastrointestinal Product and Solutions
Table 48. Boehringer Ingelheim Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Boehringer Ingelheim Recent Developments and Future Plans
Table 50. Purdue Pharma Company Information, Head Office, and Major Competitors
Table 51. Purdue Pharma Major Business
Table 52. Purdue Pharma Gastrointestinal Product and Solutions
Table 53. Purdue Pharma Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Purdue Pharma Recent Developments and Future Plans
Table 55. C.B. Fleet Company Information, Head Office, and Major Competitors
Table 56. C.B. Fleet Major Business
Table 57. C.B. Fleet Gastrointestinal Product and Solutions
Table 58. C.B. Fleet Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. C.B. Fleet Recent Developments and Future Plans
Table 60. Abbott Company Information, Head Office, and Major Competitors
Table 61. Abbott Major Business
Table 62. Abbott Gastrointestinal Product and Solutions
Table 63. Abbott Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Abbott Recent Developments and Future Plans
Table 65. Jiangzhong Company Information, Head Office, and Major Competitors
Table 66. Jiangzhong Major Business
Table 67. Jiangzhong Gastrointestinal Product and Solutions
Table 68. Jiangzhong Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Jiangzhong Recent Developments and Future Plans
Table 70. Xian-Janssen Company Information, Head Office, and Major Competitors
Table 71. Xian-Janssen Major Business
Table 72. Xian-Janssen Gastrointestinal Product and Solutions
Table 73. Xian-Janssen Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Xian-Janssen Recent Developments and Future Plans
Table 75. Global Gastrointestinal Revenue (USD Million) by Players (2018-2023)
Table 76. Global Gastrointestinal Revenue Share by Players (2018-2023)
Table 77. Breakdown of Gastrointestinal by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Gastrointestinal, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 79. Head Office of Key Gastrointestinal Players
Table 80. Gastrointestinal Market: Company Product Type Footprint
Table 81. Gastrointestinal Market: Company Product Application Footprint
Table 82. Gastrointestinal New Market Entrants and Barriers to Market Entry
Table 83. Gastrointestinal Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Gastrointestinal Consumption Value (USD Million) by Type (2018-2023)
Table 85. Global Gastrointestinal Consumption Value Share by Type (2018-2023)
Table 86. Global Gastrointestinal Consumption Value Forecast by Type (2024-2029)
Table 87. Global Gastrointestinal Consumption Value by Application (2018-2023)
Table 88. Global Gastrointestinal Consumption Value Forecast by Application (2024-2029)
Table 89. North America Gastrointestinal Consumption Value by Type (2018-2023) & (USD Million)
Table 90. North America Gastrointestinal Consumption Value by Type (2024-2029) & (USD Million)
Table 91. North America Gastrointestinal Consumption Value by Application (2018-2023) & (USD Million)
Table 92. North America Gastrointestinal Consumption Value by Application (2024-2029) & (USD Million)
Table 93. North America Gastrointestinal Consumption Value by Country (2018-2023) & (USD Million)
Table 94. North America Gastrointestinal Consumption Value by Country (2024-2029) & (USD Million)
Table 95. Europe Gastrointestinal Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Europe Gastrointestinal Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Europe Gastrointestinal Consumption Value by Application (2018-2023) & (USD Million)
Table 98. Europe Gastrointestinal Consumption Value by Application (2024-2029) & (USD Million)
Table 99. Europe Gastrointestinal Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Gastrointestinal Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Gastrointestinal Consumption Value by Type (2018-2023) & (USD Million)
Table 102. Asia-Pacific Gastrointestinal Consumption Value by Type (2024-2029) & (USD Million)
Table 103. Asia-Pacific Gastrointestinal Consumption Value by Application (2018-2023) & (USD Million)
Table 104. Asia-Pacific Gastrointestinal Consumption Value by Application (2024-2029) & (USD Million)
Table 105. Asia-Pacific Gastrointestinal Consumption Value by Region (2018-2023) & (USD Million)
Table 106. Asia-Pacific Gastrointestinal Consumption Value by Region (2024-2029) & (USD Million)
Table 107. South America Gastrointestinal Consumption Value by Type (2018-2023) & (USD Million)
Table 108. South America Gastrointestinal Consumption Value by Type (2024-2029) & (USD Million)
Table 109. South America Gastrointestinal Consumption Value by Application (2018-2023) & (USD Million)
Table 110. South America Gastrointestinal Consumption Value by Application (2024-2029) & (USD Million)
Table 111. South America Gastrointestinal Consumption Value by Country (2018-2023) & (USD Million)
Table 112. South America Gastrointestinal Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Middle East & Africa Gastrointestinal Consumption Value by Type (2018-2023) & (USD Million)
Table 114. Middle East & Africa Gastrointestinal Consumption Value by Type (2024-2029) & (USD Million)
Table 115. Middle East & Africa Gastrointestinal Consumption Value by Application (2018-2023) & (USD Million)
Table 116. Middle East & Africa Gastrointestinal Consumption Value by Application (2024-2029) & (USD Million)
Table 117. Middle East & Africa Gastrointestinal Consumption Value by Country (2018-2023) & (USD Million)
Table 118. Middle East & Africa Gastrointestinal Consumption Value by Country (2024-2029) & (USD Million)
Table 119. Gastrointestinal Raw Material
Table 120. Key Suppliers of Gastrointestinal Raw Materials
List of Figures
Figure 1. Gastrointestinal Picture
Figure 2. Global Gastrointestinal Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Gastrointestinal Consumption Value Market Share by Type in 2022
Figure 4. Prescription Gastrointestinal Drug
Figure 5. OTC Gastrointestinal Drug
Figure 6. Global Gastrointestinal Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Gastrointestinal Consumption Value Market Share by Application in 2022
Figure 8. Chronic Gastritis Picture
Figure 9. Functional Dyspepsia Picture
Figure 10. Peptic Ulcer Picture
Figure 11. Acute Gastroenteritis Picture
Figure 12. Others Picture
Figure 13. Global Gastrointestinal Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Gastrointestinal Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Gastrointestinal Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Gastrointestinal Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Gastrointestinal Consumption Value Market Share by Region in 2022
Figure 18. North America Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Gastrointestinal Revenue Share by Players in 2022
Figure 24. Gastrointestinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Gastrointestinal Market Share in 2022
Figure 26. Global Top 6 Players Gastrointestinal Market Share in 2022
Figure 27. Global Gastrointestinal Consumption Value Share by Type (2018-2023)
Figure 28. Global Gastrointestinal Market Share Forecast by Type (2024-2029)
Figure 29. Global Gastrointestinal Consumption Value Share by Application (2018-2023)
Figure 30. Global Gastrointestinal Market Share Forecast by Application (2024-2029)
Figure 31. North America Gastrointestinal Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Gastrointestinal Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Gastrointestinal Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Gastrointestinal Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Gastrointestinal Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Gastrointestinal Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 41. France Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Gastrointestinal Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Gastrointestinal Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Gastrointestinal Consumption Value Market Share by Region (2018-2029)
Figure 48. China Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 51. India Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Gastrointestinal Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Gastrointestinal Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Gastrointestinal Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Gastrointestinal Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Gastrointestinal Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Gastrointestinal Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Gastrointestinal Consumption Value (2018-2029) & (USD Million)
Figure 65. Gastrointestinal Market Drivers
Figure 66. Gastrointestinal Market Restraints
Figure 67. Gastrointestinal Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Gastrointestinal in 2022
Figure 70. Manufacturing Process Analysis of Gastrointestinal
Figure 71. Gastrointestinal Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets